Technology

Checkpoint Therapeutics

$3.35
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-0.59%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell CKPT and other stocks, options, and ETFs commission-free!

About CKPT

Checkpoint Therapeutics, Inc. Common Stock, also called Checkpoint Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio include CK-301, CK-101, CK-103, and CK-302. The company was founded on November 10, 2014 and is headquartered in New York, NY. The listed name for CKPT is Checkpoint Therapeutics, Inc. Common Stock.

CEO
James F. Oliviero
Employees
8
Headquarters
New York, New York
Founded
2014
Market Cap
210.54M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
899.44K
High Today
$3.45
Low Today
$3.23
Open Price
$3.37
Volume
614.40K
52 Week High
$4.50
52 Week Low
$1.05

Collections

CKPT Earnings

-$0.22
-$0.15
-$0.07
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 8, After Hours

You May Also Like

KT
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure